News

Redeye interview with Michael Brobjer

Aug 21, 2020

A new Redeye interview with Michael Brobjer, AroCell CEO, commenting interim report for the second quarter of 2020.

See the interview on Redeye’s website.

Strategy update: IDL Diagnostics

A strategy update with IDL Diagnostics was held on November 27th at Redeye, where CEO Anders Hultman and the management team presented recent achievements, spotlighted key initiatives, and discussed future opportunities looking toward 2026 and beyond. After their...

read more

Thesis projects at IDL Diagnostics.

We are pleased to recognize four outstanding students who have recently completed their thesis projects with us at IDL Diagnostics. The projects started in January 2025. Putri Rezqita and Yu Shi from Karolinska Institutet contributed their deep knowledge in health and...

read more